8 hours ago
MedPlus Health Services reported a 43% YoY rise in Q2 profit to ₹55.5 crore, driven by steady revenue growth and improved margins. Shares of MedPlus Health Services Ltd ended higher on Friday, October 31, by 0.55% at ₹762.00 on the NSE.
By Megha Rani October 31, 2025, 6:23:36 PM IST (Published)
Hyderabad-based pharmacy retail chain MedPlus Health Services Ltd on Friday, October 31, reported a 43.4% year-on-year (YoY) rise in net profit at ₹55.5 crore for the July-September quarter (Q2 FY26), compared to ₹38.7 crore a year earlier.
Revenue for the quarter grew 12% YoY to ₹1,679 crore from ₹1,576 crore, while EBITDA rose 19.9% YoY to ₹149 crore, up from ₹124.3 crore in the same period last year. The company’s operating margin expanded to 8.9%, compared to 7.9% a year ago.
#2QWithCNBCTV18 | #MedPlusHealth reports #Q2Results:
????Net profit up 43.4% at ₹55.5 Cr Vs ₹38.7 Cr (YoY)
????Revenue up 12% at ₹1,679 Cr Vs ₹1,576 Cr (YoY)
????EBITDA up 19.9% at ₹149 Cr Vs ₹124.3 Cr (YoY)
????Margin at 8.9% Vs 7.9% (YoY) pic.twitter.com/qVMVYKOk4m
— CNBC-TV18 (@CNBCTV18Live) October 31, 2025
As stated on August 4, MedPlus Health aims to add 600 new outlets by the end of FY26, having already achieved a net increase of 100 stores this quarter. The company noted that expansion is typically slower in the first quarter but expressed confidence in meeting its full-year target.
The retailer added that even with a growing network of around 4,800 locations, it does not expect any significant impact on profitability. Gross margins are expected to improve further, helping sustain margins at current levels.
Shares of MedPlus Health Services Ltd ended higher on Friday, October 31, by 0.55% at ₹762.00 on the NSE.
